Shandong Weigao Orthopaedic Device Co. Ltd. A Capital Reinvestment Ratio

Latest as of December 2025: 0.07x

Shandong Weigao Orthopaedic Device Co. Ltd. A capital reinvestment ratio. Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥415.42 Million) in capital expenditures (CN¥27.09 Million). Check Shandong Weigao Orthopaedic Device Co. L (688161) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.07x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥415.42 Million
CNY

Capital Expenditures

CN¥27.09 Million
CNY

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2025)

Capital reinvestment ratio of Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2025. This chart tracks Shandong Weigao Orthopaedic Device Co. Ltd. A's Capital Reinvestment Ratio across 7 annual periods. Also explore how fast is Shandong Weigao Orthopaedic Device Co. L growing its equity to track the company's year-over-year net asset growth rate.

Shandong Weigao Orthopaedic Device Co. Ltd. A Capital Reinvestment Ratio by Year (2019–2025)

Shandong Weigao Orthopaedic Device Co. Ltd. A capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see 688161 cash flow conversion.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.07x CN¥415.42 Million CN¥27.09 Million ▼ -26.5%
2024 0.09x CN¥274.19 Million CN¥24.34 Million ▼ -75.3%
2023 0.36x CN¥119.44 Million CN¥42.98 Million ▲ +58.1%
2022 0.23x CN¥508.56 Million CN¥115.76 Million ▲ +59.6%
2021 0.14x CN¥788.25 Million CN¥112.41 Million ▲ +85.2%
2020 0.08x CN¥644.12 Million CN¥49.59 Million ▲ +42.1%
2019 0.05x CN¥534.15 Million CN¥28.94 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow